Research ArticleBasic Science Investigations
Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?
Samantha Y.A. Terry, Keelara Abiraj, Jasper Lok, Danny Gerrits, Gerben M. Franssen, Wim J.G. Oyen and Otto C. Boerman
Journal of Nuclear Medicine November 2014, 55 (11) 1849-1855; DOI: https://doi.org/10.2967/jnumed.114.144394
Samantha Y.A. Terry
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2Department of Imaging Sciences, Kings College London, London, United Kingdom
Keelara Abiraj
3Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland; and
Jasper Lok
4Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands
Danny Gerrits
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Gerben M. Franssen
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Wim J.G. Oyen
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Otto C. Boerman
1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 11
November 1, 2014
Can 111In-RGD2 Monitor Response to Therapy in Head and Neck Tumor Xenografts?
Samantha Y.A. Terry, Keelara Abiraj, Jasper Lok, Danny Gerrits, Gerben M. Franssen, Wim J.G. Oyen, Otto C. Boerman
Journal of Nuclear Medicine Nov 2014, 55 (11) 1849-1855; DOI: 10.2967/jnumed.114.144394
Jump to section
Related Articles
Cited By...
- In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image {alpha}v{beta}3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models
- Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study
- In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow
- RGD PET: From Lesion Detection to Therapy Response Monitoring